Thursday, 5 November 2026European Markets

ROODMICROTEC Stock Jumps By 27% In The Last 21 Sessions

Loading stream...

(VIANEWS) - Shares of ROODMICROTEC (AEX-Index: ROOD.AS) jumped by a staggering 27.91% in 21 sessions from €0.26 to €0.33 at 05:09 EST on Wednesday, after five sequential sessions in a row of losses. AEX-Index is rising 0.01% to €755.82, after three consecutive sessions in a row of gains.

About ROODMICROTEC

RoodMicrotec N.V., together with its subsidiaries, provides semiconductor supply and quality services in the Netherlands and internationally. The company offers supply chain services, wafer and component testing, qualification and reliability investigations, and failure analysis for companies that need application-specific integrated circuits. It also provides supply chain management services comprising engineering support, test engineering, wafer test, assembly, final test, back-end, qualification and reliability support, failure analysis, field return management, and storage and logistics; test engineering services, such as design for test, test time reduction, yield improvement, and data analysis for a range of devices like mixed-signal, digital, analog, and RF ICs; and wafer and component testing that includes wafer testing, component testing, component programming, straightening and scanning, and end of line of the semiconductor device services. In addition, the company offers qualification and failure analysis for the verification of the reliability of electrical and electronic systems and single devices; robustness validation test services; failure analysis of defective devices using physical, chemical, and metallurgical analytical methods; and cross-sectioning services. It serves original equipment manufacturers and fabless companies, as well as others in the automotive, telecommunications, medical, industrial, and electronic sectors. The company was founded in 1969 and is based in Deventer, the Netherlands.

Earnings Per Share

As for profitability, ROODMICROTEC has a trailing twelve months EPS of €0.03.

PE Ratio

ROODMICROTEC has a trailing twelve months price to earnings ratio of 10.9. Meaning, the purchaser of the share is investing €10.9 for every euro of annual earnings.

More news about ROODMICROTEC (ROOD.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com